Challenges in Viral Hepatitis and Liver Disease

13e édition du Challenges in Viral Hepatitis and Liver Disease reportée en 2022

Compte tenu de la pandémie COVID-19 en cours, nous avons décidé de reporter la 13e édition de notre mini-symposium «Défis de l'hépatite virale et des maladies du foie» en 2022. Rendez-vous sur notre site Web au printemps 2021 pour la date et le programme. La «Journée du Foie de la SASL», qui aura lieu 6 mai 2021 à Lausanne(programme), est une alternative très attractive en 2021, que ce soit en personne ou en ligne.

Au plaisir de vous accueillir au 13è Défis de l'hépatite virale et des maladies du foie en 2022 et avec nos meilleurs vœux,

Prof. Darius Moradpour, Chef du Service de gastro-entérologie et d'hépatologie

13^th Challenges in Viral Hepatitis and Liver Disease postponed to 2022

Given the ongoing COVID-19 pandemic we have decided to postpone the 13^th edition of our Minisymposium «Challenges in Viral Hepatitis and Liver Disease» to 2022. Please visit our website in the spring of 2021 for the date and program.

As a very attractive alternative for 2021, please attend – in person or online – the «SASL Day of the Liver» which will take place in Lausanne on May 6, 2021 (program).

Looking forward to welcoming you to the 13^th Challenges in Viral Hepatitis and Liver Disease in 2022 and with our very best wishes,

Darius Moradpour, M.D., Professor of Medicine, University of Lausanne,

Chief, Service of Gastroenterology and Hepatology, Lausanne University Hospital (CHUV)

12th Challenges in Viral Hepatitis and Liver Disease

Lausanne, 16 janvier 2020
Programme

Prof. Thomas Berg
Viral hepatitis in immuno-compromised patients

Dr. Eleni Moschouri
Clinical pearl

Dr Montserrat Fraga
Diagnosis and management of immune checkpoint inhibitor-induced liver injury

Dr Florent Artru
Clinical pearl

Prof. Francesco Negro
Eliminating viral hepatitis by 2030

11th Challenges in Viral Hepatitis and Liver Disease

Lausanne, 10 janvier 2019
Programme

Prof. Jan Felix Drexler
Evolutionary biology of hepatitis viruses

Prof. Fabien Zoulim
HBV cure - where do we stand in 2019

Dr Maxime Robert
Clinical pearl

Dr Montserrat Fraga, PD Dr Emmanuel Melloul, Prof. Alban Denys and Dr Michel Montemurro
Advances and current challenges in hepatocellular carcinoma

Prof. Christian Toso
Current trends in liver transplantation

10th Challenges in Viral Hepatitis

Lausanne, 18 janvier 2018
Programme

Prof Charles M. Rice
New models for studying HBV replication and innate immunity (ZIP file)

Prof Andreas Cerny
The tough viral hepatitis case 1

Prof Alessio Aghemo
Clinical challenges in hepatitis C - are there any left?

Dre Cristina Marcu and Prof Andreas Cerny
The tough viral hepatitis case 2

Prof Heiner Wedemeyer
Hepatitis E: What's hot in 2018?

9th Challenges in Viral Hepatitis

Lausanne, 26 janvier 2017
Programme

Prof Henry L.Y. Chan
Addressing the challenges of hepatitis B in Asia

Dr Sébastien Godat
The tough viral hepatitis case 1

Prof Jean-Michel Pawlotsky
Management of heptatitis C in 2017

PD Dr Matthias Cavassini
The tough viral hepatitis case 2

Prof Francesco Negro
Hepatitis C in Switzerland: current challenges and perspectives

8th Challenges in Viral Hepatitis

Lausanne, 28 janvier 2016
Programme

Prof. Fabien Zoulim
Hepatitis B : current challenges and perspectives for cure.

Dre Astrid Marot
The tough hepatitis C case 1.

Prof Markus Cornberg
The challenge of hepatitis D in 2016.

Drs Karim Abdelrahman et Julien Vionnet
The tough hepatitis C case 2.

Prof Markus H. Heim
Hepatocellular carcinoma: the new frontier.

7th Challenges in Viral Hepatitis

Lausanne, 22 janvier 2015
Programme

Prof. Geoffrey M. Dusheiko
Treatment of chronic hepatitis C in 2015. Whom? When? How?

Dr Roxane Hessler and PD Dr Pierre Deltenre
Interactive clinical case presentation

Dr Harry R. Dalton
The emerging challenge of hepatitis E.

Dr Konstantin Burgmann and PD Dr Pierre Deltenre
Interactive clinical case presentation

Hepatitis E: The Lausanne experience.
Dr Jérôme Gouttenoire / Molecular virology
Dr Katharine E. Darling / Seroprevalnce studies
Dr Roland Sahli / Molecular testing
Dr Christopher Doerig / Acute and chronic hepatitis E in Switzerland